|
PGK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.72734999999147E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.370300E-02 |
| Stage1-vs-Stage3 |
4.080600E-01 |
| Stage1-vs-Stage4 |
4.762100E-02 |
| Stage2-vs-Stage3 |
5.702500E-03 |
| Stage2-vs-Stage4 |
1.059230E-03 |
| Stage3-vs-Stage4 |
2.401400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.42940009723236E-10 |
| Normal-vs-Asian |
1.62592161956354E-12 |
| Caucasian-vs-AfricanAmerican |
4.636400E-01 |
| Caucasian-vs-Asian |
8.309800E-01 |
| AfricanAmerican-vs-Asian |
3.926800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.806420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62592161956354E-12 |
| Normal-vs-Age(81-100Yrs) |
1.331930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.387400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.422800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.885000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.658600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.835200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.807800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.947040E-01 |
| Classical-VS-Follicular |
3.860900E-03 |
| Classical-VS-Other |
1.456430E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.778190E-03 |
| Tall-VS-Other |
4.743400E-01 |
| Tall-VS-Normal |
1.62669877568078E-12 |
| Follicular-VS-Other |
6.850200E-02 |
| Follicular-VS-Normal |
1.86440000105037E-08 |
| Other-VS-Normal |
2.68440000228409E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.221500E-04 |
|
|
